FDA Approved: BRIVARACETAM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for brivaracetam from Aurobindo Pharma Limited. This enables the marketing of a generic brivaracetam product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• BRIVARACETAM (brivaracetam)

Snippet

SUPPL AP for BRIVARACETAM (BRIVARACETAM)